Health Inc. : Shots - Health News As spending on care rises, the business of health keeps getting more important. We feature news on and analysis of drugmakers, health insurers, hospitals, doctors and others in the business of providing health care.

Health Inc.

Friday

There are legal questions about how far employers can go to encourage participation in wellness programs. Bjorn Rune Lie/Ikon Images/Getty Images hide caption

toggle caption
Bjorn Rune Lie/Ikon Images/Getty Images

When Are Employee Wellness Incentives No Longer Voluntary?

  • Download
  • <iframe src="https://www.npr.org/player/embed/410334545/410601357" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

While governor of Texas, Rick Perry refused to accept federal funds to expand Medicaid. Rick Wilking/Reuters/Landov hide caption

toggle caption
Rick Wilking/Reuters/Landov

Texas Politicians And Businesses Feud Over Medicaid Expansion

  • Download
  • <iframe src="https://www.npr.org/player/embed/410520561/410601369" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Wednesday

Tuesday's decision by the U.S. Supreme Court to not review an ordinance passed by Alameda County, California, means that drug makers will now need to pay for collection and disposal of unused drugs in the county. iStockphoto hide caption

toggle caption
iStockphoto

Friday

Retired California school teacher Mikkel Lawrence sits with his cat, Max. Lawrence has hepatitis C and has struggled to afford the medicine he needs to treat it. April Dembosky/KQED hide caption

toggle caption
April Dembosky/KQED

Wednesday

Sen. Chuck Grassley has questions about what the feds are doing to investigate allegations of Medicare Advantage fraud. Drew Angerer/Getty Images hide caption

toggle caption
Drew Angerer/Getty Images

Tuesday

Wednesday

Corbis

Smokers More Likely To Quit If Their Own Cash Is On The Line

  • Download
  • <iframe src="https://www.npr.org/player/embed/406459255/406505254" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

An architectural rendering of the Cleveland Clinic's planned cancer center. Courtesy of the Cleveland Clinic hide caption

toggle caption
Courtesy of the Cleveland Clinic

Cancer Spawns A Construction Boom In Cleveland

  • Download
  • <iframe src="https://www.npr.org/player/embed/403523980/405125530" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Thursday

Cambrian Genomics says that what it calls a DNA printer is essentially a DNA sorter — it quickly spots and collects the desired, tailored stretch of DNA. Courtesy of Cambrian Genomics hide caption

toggle caption
Courtesy of Cambrian Genomics

DNA 'Printing' A Big Boon To Research, But Some Raise Concerns

  • Download
  • <iframe src="https://www.npr.org/player/embed/404460240/404994340" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Ann Allen (right) and Marie Birsic (left) take part in a demonstration to prevent the closure of Lakewood Hospital on Cleveland's West Side. Birsic says the neighborhood will "go down into a ghost town" once the hospital is turned into an outpatient center. Sarah Jane Tribble/WCPN hide caption

toggle caption
Sarah Jane Tribble/WCPN

Losing A Hospital In The Heart Of A Small City

  • Download
  • <iframe src="https://www.npr.org/player/embed/404647646/404859343" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday

Registered nurses Cassie Gregor (from left), Camellia Douglas and Mike Montalto monitor patients in intensive care units scattered around North Carolina. Kevin McCarthy/Carolinas HealthCare System hide caption

toggle caption
Kevin McCarthy/Carolinas HealthCare System

Staffing An Intensive Care Unit From Miles Away Has Advantages

  • Download
  • <iframe src="https://www.npr.org/player/embed/402556818/404746532" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

AstraZeneca's Nexium was the top drug in Medicare Part D's spending on prescription medicines. Daniel Acker/Bloomberg via Getty Images hide caption

toggle caption
Daniel Acker/Bloomberg via Getty Images

Thursday